Indivior Pharmaceuticals, Inc. successfully completed its U.S. Domestication on January 23, 2026, becoming the ultimate parent company of Indivior PLC, which is now its wholly-owned subsidiary. Shareholders received one share of common stock of Indivior U.S. for each share they held in Indivior U.K.